Cite

HARVARD Citation

    Yang, H. et al. (2018). HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2. Cancer letters. pp. 19-26. [Online]. 
  
Back to record